CDK2/4/6 Inhibitors

CDK2/4/6 Inhibitors

This invention relates to compounds of general Formula (I)and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoffman, Robert Louis, Chen, Ping, Palmer, Cynthia Louise, Ninkovic, Sacha, Ornelas, Martha Alicia, Nagata, Asako, Jalaie, Mehran, Nair, Sajiv Krishnan, Rui, Eugene Yuanjin, Behenna, Douglas Carl, Freeman-Cook, Kevin Daniel
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention relates to compounds of general Formula (I)and pharmaceutically acceptable salts thereof, in which R1, R2, R2A, R2B, R3, R4, R5A, R5B, R6, R7, R8, R9, p, q and r are as defined herein, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.